| Name | Title | Contact Details |
|---|---|---|
Jessica Crosbie |
VP, Global Insights and Analytics Oncology Business Unit | Profile |
Guillaume Pasquier |
VP, Head of R&D Digital & Information Technology | Profile |
Kimberly Holliday |
VP, Head of Strategic Planning & Transformation | Profile |
Giuseppe Cognetti |
Sr. Director, Head PharmSci Technology | Profile |
Enrico Maldari |
Director, U.S. Regional Security and Crisis Management Advisor | Profile |
Securing our nation’s pharmaceuticals through U.S. Manufacturing.
XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy, and polycystic kidney disease. Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease.
Depression disconnects you from life. TMS Therapy from Salience TMS Neuro Solutions reconnects you. Offices in Dallas-Fort Worth and Houston.
Novartis provides healthcare solutions that improve and extend people`s lives. We use science-based innovation to address some of society`s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. Our company is focused on industry-leading divisions with innovation power and global scale: pharmaceuticals, eye care and generic medicines Novartis is headquartered in Basel, Switzerland. Novartis Group companies employ approximately 120,000 associates and its products are available in more than 180 countries around the world.